<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title> &#187; Cardiovascular</title>
	<atom:link href="http://pharmaexecnews.com/category/pharmaceuticals/cardiovascular/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmaexecnews.com</link>
	<description></description>
	<lastBuildDate>Fri, 29 Apr 2011 14:00:12 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Preventing Damage from Heart Attacks &amp; Strokes with an Injection</title>
		<link>http://pharmaexecnews.com/biotechnology/preventing-damage-heart-attacks-strokes-injection/</link>
		<comments>http://pharmaexecnews.com/biotechnology/preventing-damage-heart-attacks-strokes-injection/#comments</comments>
		<pubDate>Tue, 26 Apr 2011 08:00:42 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Cardiovascular]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[New Drugs]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11510</guid>
		<description><![CDATA[A researching team from the University of Leicester has offered the promise of a simple injection that could be developed to restrict the damage that results from heart attacks and strokes. Described by the lead researcher as &#8216;a fascinating new achievement&#8217;, work has already begun to translate the research into novel clinical therapies.

Professor Wilhelm Schwaeble [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/preventing-damage-heart-attacks-strokes-injection/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Turning Blood Cells into &#8216;Beating&#8217; Heart Cells</title>
		<link>http://pharmaexecnews.com/biotechnology/turning-blood-cells-beating-heart-cells/</link>
		<comments>http://pharmaexecnews.com/biotechnology/turning-blood-cells-beating-heart-cells/#comments</comments>
		<pubDate>Tue, 19 Apr 2011 14:00:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Cardiovascular]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Technology]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11473</guid>
		<description><![CDATA[Researchers from Johns Hopkins have produced a simplified, cheaper, all-purpose produces they say can be utilized by scientists around the world to more safely turn blood cells into heart cells. The procedure developed by them is virus-free and produces heart cells that beat with nearly 100 percent efficiency.

&#8220;We took the recipe for this process from [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/turning-blood-cells-beating-heart-cells/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Decreasing Prostate Cancer Risk with Cardiac Drugs</title>
		<link>http://pharmaexecnews.com/pharmaceuticals/decreasing-prostate-cancer-risk-cardiac-drugs/</link>
		<comments>http://pharmaexecnews.com/pharmaceuticals/decreasing-prostate-cancer-risk-cardiac-drugs/#comments</comments>
		<pubDate>Wed, 06 Apr 2011 19:47:56 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cardiovascular]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11416</guid>
		<description><![CDATA[Researchers at the Johns Hopkins Institute have successfully shown that a drug used to treat heart disease has the effect of lowering the risk for prostate cancer.

The scientists paired laboratory and epidemiologic data to prove that men using the cardiac drug, Digoxin, had a 24 percent lower risk for prostate cancer. The researching group believe [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/pharmaceuticals/decreasing-prostate-cancer-risk-cardiac-drugs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Research to Help in Treating Fatal Blood Clots</title>
		<link>http://pharmaexecnews.com/biotechnology/research-treating-fatal-blood-clots/</link>
		<comments>http://pharmaexecnews.com/biotechnology/research-treating-fatal-blood-clots/#comments</comments>
		<pubDate>Fri, 01 Apr 2011 08:00:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Cardiovascular]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11403</guid>
		<description><![CDATA[New scientific research published by the American Heart Association has indicated that doctors are motivated to turn towards therapeutic treatments along with blood thinners to relieve patients suffering from fatal blood clots found in deep veins that ultimately travel to the lungs.

Every year, over 250,000 people in the United States fall victim to deep vein [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/research-treating-fatal-blood-clots/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Risk Loci for Cardiovascular Disease Identified</title>
		<link>http://pharmaexecnews.com/biotechnology/risk-loci-cardiovascular-disease-identified/</link>
		<comments>http://pharmaexecnews.com/biotechnology/risk-loci-cardiovascular-disease-identified/#comments</comments>
		<pubDate>Mon, 14 Mar 2011 14:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Cardiovascular]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11295</guid>
		<description><![CDATA[In a new breakthrough for the treatment and prevention of cardiovascular disease, three research groups have separately reported the discovery of new cardiovascular disease (CAD) risk genes. The international Coronary Artery Disease Genome-Wide Replication and Meta-Analysis (CARDIoGRAM) consortium carried out a meta-analysis of 14 prior genome-wide association studies involving some 87,000 individuals of European ancestry. [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/risk-loci-cardiovascular-disease-identified/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Research Proves Regrowth of Newborn Heart</title>
		<link>http://pharmaexecnews.com/biotechnology/research-proves-regrowth-newborn-heart/</link>
		<comments>http://pharmaexecnews.com/biotechnology/research-proves-regrowth-newborn-heart/#comments</comments>
		<pubDate>Thu, 10 Mar 2011 08:00:58 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Cardiovascular]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology news]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11264</guid>
		<description><![CDATA[In a breakthrough in neonatal technology, research has proved that the heart muscles of a newborn baby have the ability to grow back on its own. This promising discovery was revealed by researchers at the UT Southwestern Medical Center, who discovered that the mammalian newborn heart can heal itself completely.

Scientists working with mice removed a [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/research-proves-regrowth-newborn-heart/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drug Counterfeiting &#8211; a $200 Billion Business</title>
		<link>http://pharmaexecnews.com/biotechnology/drug-counterfeiting-200-billion-business/</link>
		<comments>http://pharmaexecnews.com/biotechnology/drug-counterfeiting-200-billion-business/#comments</comments>
		<pubDate>Fri, 27 Aug 2010 08:00:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Cardiovascular]]></category>
		<category><![CDATA[Central Nervous System]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Generics]]></category>
		<category><![CDATA[Government Policy]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Women's Health]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biomolecules]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[generic drugs]]></category>
		<category><![CDATA[lymphoma]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Strategic Alliances in World Pharma and Biotech Markets]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10638</guid>
		<description><![CDATA[Drug counterfeiting has become a $200-billion business annually, according to the World Customs Organization. By some calculations, the counterfeiting trade has become more lucrative than the narcotics business. It&#8217;s a global problem. The World Health Organization estimates that counterfeit drugs make up ten percent of the drug market worldwide. And experts say that solving it&#8211;or [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/drug-counterfeiting-200-billion-business/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fastest Growing Therapeutic Classes (by Sales)</title>
		<link>http://pharmaexecnews.com/biotechnology/fastest-growing-therapeutic-classes-sales/</link>
		<comments>http://pharmaexecnews.com/biotechnology/fastest-growing-therapeutic-classes-sales/#comments</comments>
		<pubDate>Tue, 27 Jul 2010 08:00:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Analgesics]]></category>
		<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Cardiovascular]]></category>
		<category><![CDATA[Central Nervous System]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Companies]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Drug Trials]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Generics]]></category>
		<category><![CDATA[Government Policy]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Respiratory]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[adenoviruses]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biomolecules]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[Breast cancer]]></category>
		<category><![CDATA[c reactive protein]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[generic drugs]]></category>
		<category><![CDATA[lymph]]></category>
		<category><![CDATA[lymphoma]]></category>
		<category><![CDATA[micro technology]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Pharmacogenomics]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Proteomics]]></category>
		<category><![CDATA[Strategic Alliances in World Pharma and Biotech Markets]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10540</guid>
		<description><![CDATA[Oncologics, lipid regulators, respiratory agents, antidiabetics and anti-ulcerants are the five largest drug classes by sales. But annual sales are only half the story. Which drug classes are booming, and which have plateaued&#8211;or even dropped? IMS Health has released top-line industry data revealing the 15 largest drug classes, and we&#8217;ve crunched the numbers to take a closer [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/fastest-growing-therapeutic-classes-sales/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Magnetic Attraction of Stem Cells Creates More Potent Treatment for Heart Attack</title>
		<link>http://pharmaexecnews.com/biotechnology/magnetic-attraction-stem-cells-creates-potent-treatment-heart-attack/</link>
		<comments>http://pharmaexecnews.com/biotechnology/magnetic-attraction-stem-cells-creates-potent-treatment-heart-attack/#comments</comments>
		<pubDate>Wed, 14 Apr 2010 08:00:49 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Cardiovascular]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biomolecules]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[Gene therapy]]></category>
		<category><![CDATA[genetics]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[nanotechnology]]></category>
		<category><![CDATA[Strategic Alliances in World Pharma and Biotech Markets]]></category>
		<category><![CDATA[understanding stem cell research]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10206</guid>
		<description><![CDATA[Researchers at the Cedars-Sinai Heart Institute have found in animals that infusing cardiac-derived stem cells with micro-size particles of iron and then using a magnet to guide those stem cells to the area of the heart damaged in a heart attack boosts the heart&#8217;s retention of those cells and could increase the therapeutic benefit of [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/magnetic-attraction-stem-cells-creates-potent-treatment-heart-attack/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nanotechnology Improves Laboratory Based Heart Cell Growth</title>
		<link>http://pharmaexecnews.com/biotechnology/nanotechnology-improves-laboratory-based-heart-cell-growth/</link>
		<comments>http://pharmaexecnews.com/biotechnology/nanotechnology-improves-laboratory-based-heart-cell-growth/#comments</comments>
		<pubDate>Wed, 03 Feb 2010 08:00:21 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Cardiovascular]]></category>
		<category><![CDATA[Devices and Technology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medical Procedures]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Nanotechnology]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[biochip]]></category>
		<category><![CDATA[biochips]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[nano]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[nanotechnology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=9957</guid>
		<description><![CDATA[Many different cell types can be cultivated in a petri dish. Unfortunately, turning them into organs is substantially more difficult.  It also tends to be difficult to cultivate cells that will function in a way that is similar to normal tissue function.  This is an especially critical issue when it comes to heart cells.  Recently, [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/nanotechnology-improves-laboratory-based-heart-cell-growth/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

